A study on the measures of vague data under picture fuzzy and neutrosophic environments in the decision making processes
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
newline The evolving landscape of decision-making processes necessitates sophisticated tools capable of handling uncertainty and imprecision. This thesis delves into the realms of Picture Fuzzy Sets (PFSs) and Single-Valued Neutrosophic Sets (SVNSs), two potent mathematical frameworks designed to manage complex information in ambiguous environments. PFS (SVNS) is a more frequent platform for describing the degree of positive (truth), neutral (indeterminacy), and negative (falsity) membership functions that generalize the concept of Fuzzy Sets (FSs) and Intuitionistic Fuzzy sets (IFSs). The primary objective of this research is to develop and analyse novel models and methodologies within the picture fuzzy and single-valued neutrosophic environments. Neutrality (indeterminacy) is a crucial component of PFS (SVNS), and the score function plays a crucial role in ranking the alternatives in decision-making situations. In the decision-making process, some researchers concentrate on the development of various aggregation operators while ignoring the development of score functions. This factor causes several errors in the existing score function. If there are two separate Picture Fuzzy Numbers (PFNs) (Single-Valued Neutrosophic Numbers (SVNs)), there should be two different scores or accuracy values. Some researchers failed to rank the alternatives when the score and accuracy values for various PFNs (SVNs) were equal. To overcome the shortcomings, we proposed the perfect score function in this thesis for ranking PFNs (SVNs) and introduced strong and weak PFSs (SVNSs). The shortcomings of the existing score function in PFNs (SVNs) have been highlighted in this thesis. Furthermore, the decision making approach has been depicted based on the proposed score function, and real-world applications have been shown by ranking the COVID-19-affected regions to demonstrate its efficacy.